Immune checkpoint proteins as a prognostic biomarker of overall survival in non-small cell lung cancer: A meta-analysis and systematic review

被引：1
|
作者：
Tan, H. N. [1 ]
Rodriguez, C. C. [2 ]
Monte, K. A. [2 ]
Tan, P. G. [2 ]
Cornelio, G. D. H. [2 ]
机构：
[1] Univ Philippines, Philippine Gen Hosp, Med Oncol Dept, Manila, Philippines
[2] Philippine Gen Hosp, Med Oncol, Manila, Philippines
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.227
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
106P
引用
收藏
页码：S283 / S283
页数：1
相关论文
共 50 条
  • [1] Efficacy of immune checkpoint inhibitors in non-small cell lung cancer: A systematic review and meta-analysis
    Yang, Fang
    Wang, Yucai
    Tang, Lin
    Mansfield, Aaron Scott
    Adjei, Alex A. A.
    Leventakos, Konstantinos
    Duma, Narjust
    Wei, Jia
    Wang, Lifeng
    Liu, Baorui
    Molina, Julian R. R.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [2] Brain metastases and immune checkpoint inhibitors in non-small cell lung cancer: a systematic review and meta-analysis
    Haizhu Chen
    Yu Feng
    Yu Zhou
    Yunxia Tao
    Le Tang
    Yuankai Shi
    Cancer Immunology, Immunotherapy, 2022, 71 : 3071 - 3085
  • [3] Immune checkpoint inhibitors in neoadjuvant therapy of non-small cell lung cancer: a systematic review and meta-analysis
    Ge, Sa
    Huang, Chenjun
    JOURNAL OF THORACIC DISEASE, 2022, 14 (02) : 333 - 342
  • [4] Brain metastases and immune checkpoint inhibitors in non-small cell lung cancer: a systematic review and meta-analysis
    Chen, Haizhu
    Feng, Yu
    Zhou, Yu
    Tao, Yunxia
    Tang, Le
    Shi, Yuankai
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (12) : 3071 - 3085
  • [5] Efficacy and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer: A systematic review and meta-analysis
    Feng, Yu
    Tao, Yunxia
    Chen, Haizhu
    Zhou, Yu
    Tang, Le
    Liu, Chenwei
    Hu, Xingsheng
    Shi, Yuankai
    THORACIC CANCER, 2023, 14 (25) : 2536 - 2547
  • [6] Vascular events with immune checkpoint inhibitors in melanoma or non-small cell lung cancer: A systematic review and meta-analysis
    Giustozzi, Michela
    Becattini, Cecilia
    Roila, Fausto
    Agnelli, Giancarlo
    Mandala, Mario
    CANCER TREATMENT REVIEWS, 2021, 100
  • [7] Immune checkpoint inhibitors in oncogene-addicted non-small cell lung cancer: a systematic review and meta-analysis
    Guaitoli, Giorgia
    Tiseo, Marcello
    Di Maio, Massimo
    Friboulet, Luc
    Facchinetti, Francesco
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (06) : 2890 - 2916
  • [8] Endocrine Dysfunction of Immune Checkpoint Inhibitor in Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
    Yang, F.
    Lin, L.
    Chen, X.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [9] Safety and efficacy of retreatment with immune checkpoint inhibitors in non-small cell lung cancer: a systematic review and meta-analysis
    Cai, Zijing
    Zhan, Ping
    Song, Yong
    Liu, Hongbing
    Lv, Tangfeng
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, : 1555 - 1566
  • [10] Prognostic factors for overall survival of stage III non-small cell lung cancer patients on computed tomography: A systematic review and meta-analysis
    van Laar, Myra
    van Amsterdam, Wouter A. C.
    van Lindert, Anne S. R.
    de Jong, Pim A.
    Verhoeff, Joost J. C.
    RADIOTHERAPY AND ONCOLOGY, 2020, 151 : 152 - 175
12345